rs199931920
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_006514.4(SCN10A):c.4396C>T(p.Gln1466*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000677 in 1,550,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006514.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006514.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN10A | NM_006514.4 | MANE Select | c.4396C>T | p.Gln1466* | stop_gained | Exon 27 of 28 | NP_006505.4 | ||
| SCN10A | NM_001293306.2 | c.4393C>T | p.Gln1465* | stop_gained | Exon 26 of 27 | NP_001280235.2 | |||
| SCN10A | NM_001293307.2 | c.4102C>T | p.Gln1368* | stop_gained | Exon 25 of 26 | NP_001280236.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | TSL:1 MANE Select | c.4396C>T | p.Gln1466* | stop_gained | Exon 27 of 28 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.4393C>T | p.Gln1465* | stop_gained | Exon 26 of 27 | ENSP00000495595.1 | |||
| SCN10A | ENST00000655275.1 | c.4420C>T | p.Gln1474* | stop_gained | Exon 27 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152202Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000858 AC: 17AN: 198228 AF XY: 0.0000477 show subpopulations
GnomAD4 exome AF: 0.0000651 AC: 91AN: 1398142Hom.: 0 Cov.: 31 AF XY: 0.0000595 AC XY: 41AN XY: 688788 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
Observed in a large cohort of individuals with cardiovascular disease traits; however, segregation and clinical information were not provided (PMID: 31345219); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; This variant is associated with the following publications: (PMID: 31345219)
Brugada syndrome Benign:1
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at